Bone-Strengthening Treatment After Hip Fracture
You should start treatment with an oral bisphosphonate (alendronate or risedronate) as first-line therapy, as all men with a prior hip fracture are strongly recommended to receive anti-osteoporosis medication to prevent future fractures. 1
Why Treatment is Essential for You
Your hip fracture qualifies you for immediate osteoporosis treatment without needing further risk assessment. 1 Prior fracture is one of the strongest predictors of future fractures, and treatment significantly reduces your risk of experiencing another devastating fracture. 1, 2
First-Line Treatment Recommendation
Oral bisphosphonates (alendronate or risedronate) are the recommended first-line medications for men at high fracture risk. 1 These medications:
- Reduce vertebral fractures by 50-70% 3
- Reduce non-vertebral fractures by 20-30% 3
- Reduce hip fractures by approximately 40% 3, 2
- Have well-established safety profiles in men 1
The 2024 Nature Reviews Rheumatology guidelines provide the strongest evidence supporting bisphosphonates as first-line therapy specifically for men with osteoporosis. 1
Alternative Treatment Options
If you cannot tolerate oral bisphosphonates or have contraindications (such as esophageal problems, inability to sit upright for 30 minutes, or severe kidney disease), second-line options include: 1
- Denosumab (subcutaneous injection every 6 months) 1
- Zoledronic acid (intravenous infusion once yearly) 1, 4
Recent evidence shows that intravenous zoledronate can be safely administered as early as postoperative day 2 after hip fracture surgery, with excellent outcomes. 4
Essential Supportive Measures
You must ensure adequate vitamin D and calcium intake, as this is a strong recommendation for all men over age 65. 1 Without adequate vitamin D and calcium, bone-strengthening medications cannot work optimally.
Physical exercise and a balanced diet are strongly recommended as part of your comprehensive bone health strategy. 1
Pre-Treatment Assessment
Your doctor should check your serum testosterone level as part of your evaluation, as low testosterone can contribute to osteoporosis in men. 1 If levels are low, testosterone replacement therapy may be considered alongside your bone-strengthening medication.
Critical Adherence Information
Be aware that up to 64% of men stop taking bisphosphonates within 12 months. 1 This is a major pitfall that significantly increases your risk of future fractures. 5 The medication only works if you take it consistently. Studies show that compliance with treatment (taking medication at least 80% of days) is achieved in only about half of patients. 5
Treatment Duration and Monitoring
- Oral bisphosphonates are typically used for up to 10 years 3
- Intravenous zoledronic acid is typically used for up to 6 years 3
- Your doctor may recommend "drug holidays" of 1-2 years after prolonged use to minimize rare side effects like atypical femoral fractures 3
- Bone turnover markers can be used to monitor your adherence and response to treatment 1
Common Pitfalls to Avoid
Do not delay starting treatment. Undertreatment of osteoporosis after hip fracture increases your risk of death, disability, and recurrent fractures. 5 Only 40% of hip fracture patients receive appropriate osteoporosis treatment within one year. 5
Take oral bisphosphonates correctly: on an empty stomach, with a full glass of water, remaining upright for at least 30 minutes afterward to prevent esophageal irritation. 3
Do not stop treatment without consulting your doctor, even if you feel well, as the protective effects disappear when medication is discontinued. 3